Dexpin Tablets (Dexibuprofen)

Adult dose

○ Adults: Administer 400 mg of dexibuprofen orally 2～3 times daily. However, do not exceed 1,200 mg of dexibuprofen per day.

Individuals who regularly consume more than three glasses of alcohol daily should consult a physician or pharmacist before taking this medication, as it carries a risk of gastrointestinal bleeding. Furthermore, this medication may affect the cardiovascular system, potentially increasing the risk of myocardial infarction or stroke. Patients with cardiovascular diseases or risk factors need to be cautious and seek medical attention immediately if symptoms appear. This medication may cause gastrointestinal adverse reactions such as gastrointestinal bleeding, ulcers, and perforation, which necessitates extra caution in elderly patients or those on long-term therapy. Patients with a history of gastrointestinal ulcers or bleeding, severe liver or kidney impairment, heart failure, high blood pressure, or asthma should avoid taking this medication. This medication contains Yellow No. 5 dye, and those allergic to this component should use it cautiously. Co-administration with aspirin or other non-steroidal anti-inflammatory drugs may increase the risk of gastrointestinal bleeding; thus, it is advisable not to take them together. During treatment with this medication, breastfeeding should be paused or discussed with a physician, and caution is advised for activities requiring alertness, such as driving or operating machinery, due to potential dizziness or fatigue. Patients with blood disorders, liver impairment, kidney impairment, hypertension, heart failure, or hypersensitivity reactions should consult a healthcare professional before use. This medication may interact with various drugs, so if you are taking other medications, inform your physician or pharmacist. If skin rash, difficulty breathing, severe headache, or symptoms of gastrointestinal bleeding occur during use, stop taking the medication immediately and consult a healthcare professional. Particularly during the last six months of pregnancy, this medication should be avoided as it could affect the fetus, and women planning to become pregnant or in early pregnancy should consult a healthcare professional. This medication should be used at the lowest effective dose for the shortest duration, and regular check-ups and monitoring by healthcare professionals are necessary during long-term use. In case of overdose, visit a medical institution immediately for appropriate treatment. Store this medication out of reach of children, away from direct sunlight, and in a cool, dry place.

Gastrointestinal bleeding, serious cardiovascular thrombotic reactions, myocardial infarction, stroke, bleeding in the stomach or intestines, ulcers, perforation, dyspepsia, abdominal distension, heartburn, upper abdominal pain, diarrhea, constipation, loss of appetite, nausea, vomiting, abdominal pain, discomfort in the upper abdomen, esophagitis, esophageal stricture, aggravation of diverticulitis, nonspecific hemorrhagic colitis, ulcerative colitis, Crohn's disease, peptic ulcer with gastrointestinal bleeding, perforation, bloody stools, gastritis, pancreatitis, dry mouth, stomatitis, erythema multiforme, systemic lupus erythematosus, hair loss, angioedema, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia, drug rash with systemic symptoms, acute generalized pustular psoriasis, rash, hives, itching, purpura, asthma attacks, eczema, anaphylactic reaction, photosensitivity reaction, jaundice, elevated ALT, elevated AST, elevated ALP, hepatic dysfunction, hepatitis, rhinitis, bronchospasm, acute pneumonia, disregard, cancer invasion, hearing loss, tinnitus, taste disorder, fatigue, drowsiness, headache, dizziness, anxiety, restlessness, confusion, depression, aseptic meningitis, mental disturbances, agitation, excitement, disturbance of orientation, reversible toxic myopathy, hypotension, hypertension, palpitations, acute renal failure, oliguria, hematuria, increased urinary protein, increased BUN, elevated serum creatinine, hyperkalemia, decreased urine output, generalized edema, shortness of breath, lethargy, renal papillary necrosis, nephrotic syndrome, interstitial nephritis, peripheral edema, acute pulmonary edema, fluid retention, Conis syndrome, reduced reproductive capability in women, periorbital edema, fatigue, fever, nosebleeds, exacerbation of inflammation, moaning, facial edema, dyspepsia, pruritus, anaphylactic shock, rash, oligohydramnios, neonatal kidney impairment

This medication should be stored in a tightly sealed container to protect it from air and moisture, ideally at a temperature between 1 and 30 degrees Celsius. Storing it this way helps maintain its effectiveness for a longer period.

Appearance

Pink oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle, 500 tablets/bottle